Latest News in Pharma industry

1 day ago

AstraZeneca Signs $5.3 Billion AI Drug Discovery Deal with Chinese Firm CSPC

1 day ago

FDA Approves Moderna's RSV Vaccine for Younger At-Risk Adults Aged 18-59

2 days ago

J&J's New Leukemia Drug Shows 90% Response Rate in Early Trials

2 days ago

FDA Approves Nuvation Bio's New Lung Cancer Drug IBTROZI With 90% Response Rate

3 days ago

Novo Nordisk Invests $812 Million in AI Drug Discovery Deal for New Obesity Treatment

5 days ago

Samsung Bioepis Partners with NIPRO to Bring Multiple Biosimilars to Japanese Market

8 days ago

Rare Kidney Disease Patients See Hope as EMPAVELI Maintains Strong Results After One Year

10 days ago

Roche's New Room-Temperature SMA Tablet Wins European Approval, Expanding Treatment Access

12 days ago

Bristol Myers Squibb Commits $11.1 Billion to Partner with BioNTech on Dual-Target Cancer Drug

12 days ago

AstraZeneca's IMFINZI Reduces Gastric Cancer Recurrence Risk by 29% in Landmark Trial

16 days ago

Biohaven's New Kidney Disease Drug Shows 81% Reduction in Key Disease Marker During Early Testing

17 days ago

Rocket Pharma Stock Plunges 62.8% After Patient Death Halts Gene Therapy Trial

18 days ago

Lilly's $1 Billion Bet on Pain - Acquisition Targets the Next Frontier in Non-Opioid Treatment

19 days ago

China's Mazdutide Weight Loss Drug Shows 15% Effectiveness in Major Medical Journal Study

20 days ago

SpringWorks' NF1 Drug Mirdametinib Wins European Regulator Support for Adults and Children

22 days ago

Countdown to Cash Crisis - The High-Stakes Proxy War at MediPharm Labs

22 days ago

FDA Warning on Allergy Drug Withdrawal Side Effects Shakes Pharmaceutical Market While Creating Investment Opportunities

23 days ago

Sanofi Acquires Alzheimer's Drug Developer Vigil Neuroscience for $600 Million to Advance Brain-Penetrating TREM2 Therapy

24 days ago

FDA Panel Backs First Treatment for High-Risk Smoldering Multiple Myeloma

25 days ago

Persist AI Raises $12M and Launches Cloud Lab Platform to Transform Pharmaceutical Formulation Speed

25 days ago

AstraZeneca's Breakthrough Asthma Treatment Challenges 50 Years of Standard Care

27 days ago

Novo Nordisk's Leadership Crisis - Strategic Implications of Jørgensen's Surprise Exit

29 days ago

Takeda's Narcolepsy Drug Shows Breakthrough Results in Restoring Normal Wakefulness for Patients

30 days ago

Pathos AI Raises $365 Million to Build Largest Multimodal Foundation Model for Cancer Drug Development

30 days ago

In a First for a Rare Cancer, Merck Secures FDA Nod for WELIREG — But Market Access and Safety Risks Loom Large

31 days ago

UnitedHealth Shares Plunge as Former CEO Hemsley Returns Following Witty's Abrupt Exit

37 days ago

Amgen Wins UK Approval for First Targeted Thyroid Eye Disease Treatment as Pressure Mounts from Cheaper Rivals

40 days ago

Early Trial Shows REC-4881 Reduces Polyp Burden by 43 Percent in Rare Genetic Cancer Disorder

41 days ago

Gene Therapy Market Shaken as Vertex Abandons AAV Technology Amid Safety Concerns and Regulatory Upheaval

42 days ago

Pykus Therapeutics' Novel Retinal Sealant Shows 91% Success Rate in Early Trials, Eliminating Need for Face-Down Recovery

44 days ago

Semaglutide Shows Strong Results in Major Liver Disease Trial, FDA Review Now Underway

45 days ago

Semaglutide Safety Concerns Mount as CDC Links Popular Weight Loss Drugs to Over 24,000 Emergency Room Visits

46 days ago

German Pharma Giant Merck Acquires SpringWorks for $3.9 Billion in Rare Disease Market Push

48 days ago

Pfizer's Sasanlimab-BCG Combination Shows 32% Reduction in Bladder Cancer Recurrence in Landmark Trial

51 days ago

Brensocatib Shows Statistically Significant Results in Phase 3 ASPEN Trial for Bronchiectasis According to NEJM Publication

52 days ago

Corcept's Novel Cortisol Blocker Extends Survival in Advanced Ovarian Cancer Trial

53 days ago

Swiss Pharma Giant Roche Commits $50 Billion to Build US Manufacturing Empire, Creating 12,000 Jobs

58 days ago

Zenas BioPharma Faces Lawsuit Over Allegedly Misleading IPO Financial Disclosures

60 days ago

Trump Administration Launches National Security Tariff Probes Targeting Semiconductor and Pharmaceutical Imports

64 days ago

Amgen Reports First Survival Benefit in Global Phase 3 Trial for Relapsed Small Cell Lung Cancer

64 days ago

FDA Begins Phasing Out Animal Testing for Drug Safety Using AI Models and Human Organoids

65 days ago

Trump Announces Sweeping Tariffs on Imported Pharmaceuticals Triggering Market Selloff and Industry Backlash

66 days ago

Ireland Emerges as Europe's Most Vulnerable Economy in US-EU Tariff War

67 days ago

DHL Commits €2 Billion to Expand Global Healthcare Logistics Network by 2030

68 days ago

Genetic Test Validated to Predict Long-Term Side Effects of Radiation in Prostate Cancer Patients

71 days ago

BeiGene Retreats from Anti-TIGIT Bet, Exposing Industry-Wide Fault Lines in Immuno-Oncology

73 days ago

Why Genentech's 'Disappointing' MS Trial Outcome Might Be Its Most Reassuring Result Yet

73 days ago

Pfizer Faces Shareholder Backlash as Proxy Firm Opposes CEO’s $33 Million Pay Amid Revenue and Stock Decline

74 days ago

Chinese AI Biotech Sector Faces Downturn as Another Startup Struggles

75 days ago

Lilly’s Lepodisiran Cuts Genetic Heart Risk Factor by 94 Percent in Phase 2 Trial with Effects Lasting 1.5 Years